Cytosorbents News

CytoSorbents Analyst Ratings

BenzingaMay 15 10:04 ET

B. Riley Securities Reiterates Buy on CytoSorbents, Maintains $3 Price Target

BenzingaMay 15 10:06 ET

Hold Rating on Cytosorbents Amid Regulatory Uncertainties and Mixed Clinical Results

TipRanksMay 7 07:46 ET

CytoSorbents Analyst Ratings

BenzingaMay 7 06:55 ET

CytoSorbents Analyst Ratings

BenzingaMar 15 06:39 ET

Cytosorbents Financial and Clinical Study Outlook: Maintaining a Hold Rating

TipRanksMar 15 06:27 ET

CytoSorbents Holds Steady With Neutral Rating Amid Clinical and Financial Reassessments

TipRanksDec 29, 2023 10:56 ET

CytoSorbents Analyst Ratings

BenzingaDec 29, 2023 10:42 ET

B. Riley Trims Price Target on Cytosorbents to $3 From $4, Maintains Buy Rating

MT NewswiresDec 28, 2023 11:48 ET

Promising Financial Outlook and Potential Game-Changer Study Drive Buy Rating for Cytosorbents

TipRanksNov 10, 2023 07:00 ET

CytoSorbents Analyst Ratings

BenzingaSep 7, 2023 08:27 ET

Watching CytoSorbents; Hearing Zacks Small-Cap Research Sets $6 Price Target; Says CytoSorbents Reports 2nd Quarter 2023 Financial And Operating Results Which Showed Strong Product Revenue Growth And An Improved Cost Structure

BenzingaAug 3, 2023 13:14 ET

CytoSorbents Analyst Ratings

BenzingaAug 2, 2023 06:21 ET

H.C. Wainwright Reaffirms Their Buy Rating on Cytosorbents (CTSO)

TipRanksAug 2, 2023 06:15 ET

HC Wainwright & Co. Reiterates Buy on CytoSorbents, Maintains $5.5 Price Target

BenzingaMay 3, 2023 06:41 ET

Analysts Offer Insights on Healthcare Companies: Aurinia Pharmaceuticals (AUPH) and Cytosorbents (CTSO)

TipRanksMay 3, 2023 06:37 ET

Cytosorbents (CTSO) Gets a Buy From H.C. Wainwright

TipRanksMar 10, 2023 06:33 ET

HC Wainwright & Co. Reiterates Buy on CytoSorbents, Maintains $5.5 Price Target

BenzingaMar 10, 2023 06:27 ET

HC Wainwright Adjusts Price Target on Cytosorbents to $5.50 From $9, Maintains Buy Rating

MT NewswiresNov 4, 2022 12:00 ET

CytoSorbents Analyst Ratings

Benzinga Analyst RatingsNov 4, 2022 06:28 ET